Remifentanil's Effect on EEG Burst Suppression During Anesthesia
This study aims to examine how remifentanil affects brain activity patterns, specifically burst suppression, during anesthesia in individuals receiving propofol.
High dose of remifentanil
+ Medium dose of remifentanil
Basic Science Study
Summary
Study start date: March 1, 2024
Actual date on which the first participant was enrolled.This study aims to examine how different levels of the drug Remifentanil affect brain activity in patients undergoing general anesthesia with Propofol. It specifically looks at a phenomenon called burst suppression, which can be seen in brain waves during deep anesthesia. The study is important because understanding how these drugs interact can help improve anesthesia practices, ensuring patients remain safely unconscious during surgery while minimizing potential side effects. The study targets individuals who require surgery under general anesthesia, addressing the need to optimize drug doses for better patient care. Participants in the study will receive anesthesia in a controlled hospital setting. Initially, an intravenous cannula is placed to administer the drugs, and participants will have their brain activity monitored using an EEG device. The study involves adjusting the doses of Remifentanil and Propofol and recording the resulting changes in brain activity. Participants will be intubated after losing consciousness, and the drug levels will be varied according to the study's design. Throughout the procedure, usual medications will be used to maintain stable heart and blood pressure levels. The study does not mention specific risks or benefits, but it is focused on improving the understanding of anesthesia effects on brain activity.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * American Society of Anesthesiology I or II * Elective surgery of low or intermediate risk Exclusion Criteria: * Neurological disease * Psychiatric disease * Use of psychoactive drugs or opioids * Altered basal state of consciousness * Allergy to propofol * Body mass index \> 35 kg/m2 * Pre-existing renal, cardiac and/or hepatic dysfunction * Patient's refusal to participate
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile
Santiago, ChileOpen Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile in Google MapsHospital Clinico de la Universidad de Chile
Santiago, Chile